Related Experiment Video
Updated: Jan 13, 2026

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
Diabetes-Related Hospitalizations From 2018-2023 for Children With Type 2 Diabetes
Candace D Gildner1, Matt Hall2, Nathaniel D Bayer1
1Division of Pediatric Hospital Medicine, Department of Pediatrics, University of Rochester and Golisano Children's Hospital, Rochester, New York.
Objective:
Hospitalizations in the United States for type 2 diabetes (T2D) diagnoses in youth increased precipitously in 2020 and 2021. The subsequent trend in hospitalizations for T2D in youth is unknown. We aimed to analyze this trend from 2018 to 2023 and determine frequencies of comorbidities.
Methods:
We collected semiannual counts of hospitalizations over this period for patients aged 1 to 20 years with T2D-related principal discharge billing diagnoses from 40 children's hospitals in the Pediatric Hospital Information System. We stratified data by diagnoses, sociodemographics, and quintiles of Childhood Opportunity Index 3.0. We then performed trend analyses and examined frequencies of hypertension, mental health diagnoses, and renal disease.
Results:
In 2023, hospitalizations for T2D were 13.1% higher than in 2018 (n = 1484 vs 1679) but declined 43% from their peak in 2021 (n = 2967). The percentage of these hospitalizations due to diabetic ketoacidosis (DKA) rose from 2018 (23.2%) to 2023 (31.8%). Although individuals aged 15 years or older accounted for the highest percentage of T2D-related hospitalizations (47.1%), the percentage of T2D-related hospitalizations for youth aged under 9 years rose significantly from 2018 (5.5%) to 2023 (8.5%). In 2022 and 2023, Hispanic individuals (34.1%) accounted for the highest percentage of T2D-related hospitalizations followed by non-Hispanic Black (30.8%) and non-Hispanic white (27.3%) individuals. Comorbid mental health diagnoses (25.8%) and hypertension (10.7%) were observed throughout the study period.
Conclusion:
In 2023, T2D-related hospitalizations remained higher than pre-COVID-19 levels, and DKA accounted for a higher percentage of these hospitalizations, demonstrating increased hospital resource use for youth-onset T2D.
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes: Symptoms, Diagnosis, and Complications
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...

